277 related articles for article (PubMed ID: 10648729)
21. Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia.
Auh QS; Chun YH; Melemedjian OK; Zhang Y; Ro JY
Brain Res Bull; 2016 Jul; 125():211-7. PubMed ID: 27450703
[TBL] [Abstract][Full Text] [Related]
22. Activation of mu-opioid receptors inhibits synaptic inputs to spinally projecting rostral ventromedial medulla neurons.
Finnegan TF; Li DP; Chen SR; Pan HL
J Pharmacol Exp Ther; 2004 May; 309(2):476-83. PubMed ID: 14724227
[TBL] [Abstract][Full Text] [Related]
23. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
24. Role of opioid receptors (mu, delta 1, delta 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat.
Wang XM; Yan JQ; Zhang KM; Mokha SS
Brain Res; 1996 Nov; 739(1-2):235-43. PubMed ID: 8955943
[TBL] [Abstract][Full Text] [Related]
25. Analysis of dopamine receptor antagonism upon feeding elicited by mu and delta opioid agonists in the shell region of the nucleus accumbens.
Ragnauth A; Znamensky V; Moroz M; Bodnar RJ
Brain Res; 2000 Sep; 877(1):65-72. PubMed ID: 10980244
[TBL] [Abstract][Full Text] [Related]
26. Activation of mu-opioid receptors in rat ventrolateral medulla selectively blocks baroreceptor reflexes while activation of delta opioid receptors blocks somato-sympathetic reflexes.
Miyawaki T; Goodchild AK; Pilowsky PM
Neuroscience; 2002; 109(1):133-44. PubMed ID: 11784705
[TBL] [Abstract][Full Text] [Related]
27. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia.
Zhou L; Zhang Q; Stein C; Schäfer M
J Pharmacol Exp Ther; 1998 Aug; 286(2):1000-6. PubMed ID: 9694961
[TBL] [Abstract][Full Text] [Related]
28. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
[TBL] [Abstract][Full Text] [Related]
29. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
Schmidt BL; Tambeli CH; Levine JD; Gear RW
Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
[TBL] [Abstract][Full Text] [Related]
30. Genetic differences in response properties of rostral ventromedial medulla neurons to the μ-opioid receptor agonist DAMGO in mouse inbred strains.
Sugino S; Namiki A; Yamakage M
Neurosci Lett; 2012 May; 517(2):107-12. PubMed ID: 22546603
[TBL] [Abstract][Full Text] [Related]
31. Cellular basis for opioid potentiation in the rostral ventromedial medulla of rats with persistent inflammatory nociception.
Zhang L; Hammond DL
Pain; 2010 Apr; 149(1):107-116. PubMed ID: 20172653
[TBL] [Abstract][Full Text] [Related]
32. A cellular mechanism for the antinociceptive effect of a kappa opioid receptor agonist.
Ackley MA; Hurley RW; Virnich DE; Hammond DL
Pain; 2001 Apr; 91(3):377-388. PubMed ID: 11275396
[TBL] [Abstract][Full Text] [Related]
33. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance.
Vanderah TW; Gardell LR; Burgess SE; Ibrahim M; Dogrul A; Zhong CM; Zhang ET; Malan TP; Ossipov MH; Lai J; Porreca F
J Neurosci; 2000 Sep; 20(18):7074-9. PubMed ID: 10995854
[TBL] [Abstract][Full Text] [Related]
34. Mu and delta opioid synergy between the periaqueductal gray and the rostro-ventral medulla.
Rossi GC; Pasternak GW; Bodnar RJ
Brain Res; 1994 Nov; 665(1):85-93. PubMed ID: 7882023
[TBL] [Abstract][Full Text] [Related]
35. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
36. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
Gyires K; Rónai AZ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
[TBL] [Abstract][Full Text] [Related]
37. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal.
Aley KO; Green PG; Levine JD
J Neurosci; 1995 Dec; 15(12):8031-8. PubMed ID: 8613740
[TBL] [Abstract][Full Text] [Related]
38. Region-dependent G-protein activation by mu-, delta 1- and delta 2-opioid receptor agonists in the brain: comparison between the midbrain and forebrain.
Tsuji M; Narita M; Mizoguchi H; Narita M; Ohsawa M; Kamei J; Nagase H; Takeda H; Matsumiya T; Tseng LF
Life Sci; 1999; 65(16):PL233-9. PubMed ID: 10573190
[TBL] [Abstract][Full Text] [Related]
39. Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat.
Thorat SN; Hammond DL
J Pharmacol Exp Ther; 1997 Dec; 283(3):1185-92. PubMed ID: 9399992
[TBL] [Abstract][Full Text] [Related]
40. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
